Cargando…

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics

BACKGROUND: Empagliflozin can curb inflammation and oxidative stress, through sodium-proton exchanger (NHE) inhibition, in a model of lipotoxicity in human myeloid angiogenic cells (MAC), which mediate endothelial repairing processes. Aim of this study is to assess in human MAC whether: (1) Stearic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cinquegrani, Gloria, Spigoni, Valentina, Fantuzzi, Federica, Bonadonna, Riccardo C., Dei Cas, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851739/ https://www.ncbi.nlm.nih.gov/pubmed/35177077 http://dx.doi.org/10.1186/s12933-022-01461-4

Ejemplares similares

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events
por: Spigoni, Valentina, et al.
Publicado: (2020)

Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2017)

SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells
por: Spigoni, Valentina, et al.
Publicado: (2016)

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes
por: Dei Cas, Alessandra, et al.
Publicado: (2017)

Effects of TiO(2) and Co(3)O(4) Nanoparticles on Circulating Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2015)

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
por: Spigoni, Valentina, et al.
Publicado: (2017)

Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders
por: Spigoni, Valentina, et al.
Publicado: (2022)

Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?
por: Derlindati, Eleonora, et al.
Publicado: (2015)

Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2019)

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2017)

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
por: Ge, Mengyuan, et al.
Publicado: (2023)

Performance and anthropometric characteristics of Elite Rugby Players
por: Pasin, Federico, et al.
Publicado: (2017)

Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project
por: Martini, Daniela, et al.
Publicado: (2020)

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
por: Spigoni, Valentina, et al.
Publicado: (2012)

Empagliflozin prevents doxorubicin-induced myocardial dysfunction
por: Sabatino, Jolanda, et al.
Publicado: (2020)

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
por: Pietschner, R., et al.
Publicado: (2021)

β-Cell Lipotoxicity in Response to Free Fatty Acid Elevation in Prepubertal Youth: African American Versus Caucasian Contrast
por: Michaliszyn, Sara F., et al.
Publicado: (2013)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
por: Bosch, Agnes, et al.
Publicado: (2019)

The effect of placental angiogenic and anti-angiogenic factors on pregnancy outcome in patients with early onset preeclampsia
por: Kara, Mustafa, et al.
Publicado: (2021)

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
por: Sarak, Bradley, et al.
Publicado: (2021)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Does Endurance Training Protect From Lipotoxicity?
por: Roden, Michael
Publicado: (2012)

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
por: Kusaka, Hiroaki, et al.
Publicado: (2016)

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
por: Li, Chenguang, et al.
Publicado: (2019)

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
por: Lunder, Mojca, et al.
Publicado: (2018)

Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
por: Gaborit, B., et al.
Publicado: (2021)

The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
por: Daud, Elias, et al.
Publicado: (2021)

Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
por: Huang, Chiang-Chi, et al.
Publicado: (2021)

Integrated analysis of chronic lipotoxicity on muscle metabolism and stress and its reversal by antioxidants
por: Verma, Mahesh Kumar, et al.
Publicado: (2014)

Single cell cloning generates lung endothelial colonies with conserved growth, angiogenic, and bioenergetic characteristics
por: Lee, Ji Young, et al.
Publicado: (2017)

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
por: Cherney, David ZI, et al.
Publicado: (2014)

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Angiogenic effects of cryosurgery with liquid nitrogen on the normal skin of rats, through morphometric study()
por: Pimentel, Camila Bianco, et al.
Publicado: (2014)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
por: Kawamata, Hibiki, et al.
Publicado: (2017)

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
por: Aroor, Annayya R., et al.
Publicado: (2018)

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob(−/−) mice
por: Adingupu, Damilola D., et al.
Publicado: (2019)

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
por: Connelly, Kim A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ae7lnkrs0t9omtmpkl6iasfjqp